Verhaar M J, Keep P A, Hawkins R E, Robson L, Casey J L, Pedley B, Boden J A, Begent R H, Chester K A
CRC Laboratories, Department of Clinical Oncology, Royal Free Hospital School of Medicine, London, United Kingdom.
J Nucl Med. 1996 May;37(5):868-72.
Single-chain Fv (scFv) antibody fragments have potential for clinical imaging because of their rapid tumor penetration and high tumor-to-tissue ratios at early time points. ScFvs clear rapidly from the circulation so radiolabels such as 99mTc which have short half-lives are desirable, but the free thiol groups necessary for labeling with 99mTc are not normally found on these molecules.
We constructed a vector which enabled a free cysteine to be linked to the C-terminus of scFvs. MFE-23, a scFv directed against carcinoembryonic antigen (CEA), was cloned into this vector and cys-tagged MFE-23 was labeled with 99mTc using a D-glucarate transfer method.
The radiolabeled product was stable in vivo and in vitro and showed favorable tumor-to-blood ratios in vivo at early time points (4:1 at 24 hr and 8:1 at 48 hr), although high kidney levels were also detected.
Our study demonstrates an effective method to enable scFvs radiolabeling with 99mTc and also shows the potential of using a 99mTc-labeled scFv for clinical imaging studies.
单链Fv(scFv)抗体片段因其能快速穿透肿瘤且在早期时间点具有高肿瘤与组织比值,而具有临床成像的潜力。ScFv从循环中快速清除,因此像半衰期短的99mTc这样的放射性标记是理想的,但这些分子上通常不存在用99mTc标记所需的游离巯基。
我们构建了一个载体,使游离半胱氨酸能够连接到scFv的C末端。将针对癌胚抗原(CEA)的scFv MFE-23克隆到该载体中,并用D-葡萄糖醛酸转移法用99mTc标记带有半胱氨酸标签的MFE-23。
放射性标记产物在体内和体外均稳定,且在早期时间点在体内显示出良好的肿瘤与血液比值(24小时时为4:1,48小时时为8:1),尽管也检测到较高的肾脏摄取量。
我们的研究证明了一种使scFv能用99mTc进行放射性标记的有效方法,并且还显示了使用99mTc标记的scFv进行临床成像研究的潜力。